肾移植后肺动脉高压的心肺血流动力学与结局关联研究
多中心回顾性队列纳入2011年10月至2021年10月接受肾移植、且在移植前1年内行右心导管检查的成人117例,其中mPAP>20 mm Hg的PH占79%。右心导管测得mPAP≥30 mm Hg与移植后主要不良心血管事件相关,毛细血管前肺动脉高压与移植后死亡相关,而超声估测肺动脉压未能识别结局。
要点
- 右心导管mPAP≥30 mm Hg与肾移植后主要不良心血管事件及死亡相关。
- 毛细血管前肺动脉高压与肾移植后死亡相关(HR 3.71)。
- 超声估测肺动脉压未能识别肾移植后结局,右心导管血流动力学可能更优。
核心结论
- 右心导管测得的毛细血管前肺动脉高压和mPAP≥30 mm Hg与肾移植后死亡及主要不良心血管事件相关,超声证据的PH未显示关联。
- 右心导管血流动力学在关联移植后结局方面优于超声测压,mPAP可能有助于预测移植后主要不良心血管事件和死亡。
研究设计与样本
- 多中心回顾性队列研究,纳入2011年10月1日至2021年10月1日间接受肾移植、且在移植前1年内行右心导管评估心肺血流动力学的成人。
- 最终分析共117例,以男性为主(72%),中位年龄57岁。
- 采用脆弱模型和logistic回归模型评估心肺血流动力学与移植后结局的关联。
主要发现
- PH定义为mPAP>20 mm Hg,本队列中占79%(n=93)。
- 移植后中位随访29.9个月,约23%发生死亡、25%发生移植肾功能延迟恢复(DGF)、34%发生主要不良心血管事件。
- 右心导管mPAP≥30 mm Hg与移植后主要不良心血管事件相关(HR 2.60;95%CI 1.10-6.10),且在移植后死亡者中更常见(63% vs 32%;P=.001)。
- 毛细血管前肺动脉高压与移植后死亡相关(HR 3.71;95%CI 1.07-12.90)。
- 超声估测肺动脉压未能识别移植后结局。
关键数值与推荐
- PH判定标准:右心导管mPAP>20 mm Hg。
- mPAP≥30 mm Hg与移植后主要不良心血管事件相关:HR 2.60;95%CI 1.10-6.10。
- 毛细血管前肺动脉高压与移植后死亡相关:HR 3.71;95%CI 1.07-12.90。
- 移植后死亡者中mPAP≥30 mm Hg比例更高:63% vs 32%;P=.001。
临床怎么用
- 肾移植候选者评估PH时,右心导管血流动力学可能比超声测压更有助于移植后风险分层。
- 对右心导管mPAP≥30 mm Hg或毛细血管前肺动脉高压者,移植后应加强死亡和主要不良心血管事件的监测。
局限性
- 为多中心回顾性队列研究,样本量117例,可能存在选择偏倚与残余混杂。
- 仅纳入移植前1年内行右心导管者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary hypertension (PH) frequently complicates the evaluation of kidney transplantation (KT) candidates, and is associated with increased adverse outcomes (mortality, delayed graft function [DGF], and major adverse cardiovascular event) following KT. RESEARCH QUESTION: What is the relationship between cardiopulmonary hemodynamics and post-KT outcomes? STUDY DESIGN AND METHODS: We conducted a multicenter retrospective cohort study of adults undergoing KT between October 1, 2011 and October 1, 2021, who underwent right heart catheterization (RHC) to assess cardiopulmonary hemodynamics within 1 year of transplantation. Frailty models and logistic regression models were used to evaluate the association between cardiopulmonary hemodynamics and outcomes (mortality, DGF, major adverse cardiovascular event) following KT. RESULTS: A total of 117 patients were included in the final analysis, predominantly male (72%), with a median age of 57 years. PH, defined as mean pulmonary artery pressure (mPAP) > 20 mm Hg, was present in most of the cohort (n = 93; 79%). The cohort was monitored for a median of 29.9 months post-KT, during which about one-fourth experienced mortality (23%) or DGF (25%) events, and approximately one-third (34%) experienced major adverse cardiovascular event. Although echocardiographic measures of pulmonary artery pressure failed to identify post-KT outcomes, a mPAP of ≥ 30 mm Hg on RHC was associated with post-KT major adverse cardiovascular event (hazard ratio, 2.60; 95% CI, 1.10-6.10) and more prevalent in those experiencing post-KT mortality (63% vs 32%; P = .001). Precapillary pulmonary hypertension was also associated with post-KT mortality (hazard ratio, 3.71; 95% CI, 1.07-12.90). INTERPRETATION: Precapillary pulmonary hypertension and an mPAP of ≥ 30 mm Hg on RHC, but not echocardiographic evidence of PH, was associated with mortality and major adverse cardiovascular event following KT. These data suggest that RHC hemodynamics are superior to echocardiographic measures of PH in association with outcomes following KT, and RHC-derived mPAP in particular may have value in predicting major adverse cardiovascular event and mortality post-KT.
引用
- Jose A, Kumar SS, Gorelik L, et al. Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplantation: A Multicenter Retrospective Cohort Study. Chest. 2024. PMID: 39181378. doi:10.1016/j.chest.2024.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。